Fund Evaluator:
Crossmark Large Cap Value ETF (CLCV)Equity
Global Asset Class
U.S. Equity
Fund Group
Large Value
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.50% D
Expense Ratio
$17 Mil
Assets
Open
Status
na
12b-1 Fee
0.35%
TTM Yield
0.00%
Max Load
12%
Portfolio Turnover
Best Performing in Large Value Over the Last Year
| 38.6% | American Beacon Man Lg Cp Value Inv (BWLIX) |
| 37.5% | LSV Conservative Value Equity Investor (LVAVX) |
| 36.8% | PGIM Quant Solutions Large-Cap Val Z (SUVZX) |
| 36.0% | Fidelity Advisor Blue Chip Value Z (FFVPX) |
| 35.9% | Fidelity Blue Chip Value (FBCVX) |
Data as of 7/31/2026
2.2% C
1-Mo Return
8.6% A
3-Mo Return
15.0% C
YTD Return
23.5% C
1-Yr Return
na
3-Yr Return
na
5-Yr Return
na
Category Risk Index
na
Total Risk Index
Fund Details
Fund Family
Crossmark Inc
Inception Date
7/22/2025
Share Class Type
Equity Investment Style
Large-Cap
Value
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
N/A: 100%
Additional Fund Details
Crossmark Large Cap Value ETF Overview
CLCV Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| CLCV Return (NAV) | 2.2% | 8.6% | 23.5% | na | na | na |
| CLCV Grade | C | A | C | na | na | na |
| +/- Category | -0.7% | 2.4% | -0.3% | na | na | na |
| Large Value Avg | 2.9% | 6.2% | 23.8% | 15.7% | 10.9% | 11.3% |
| CLCV Tax Cost Ratio | na | na | 0.2% | na | na | na |
CLCV Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| CLCV Return (NAV) | 15.0% | na | na | na | na | na | na | na | na | na | na |
| CLCV Grade | C | na | na | na | na | na | na | na | na | na | na |
| +/- Category | 0.7% | na | na | na | na | na | na | na | na | na | na |
| Large Value Avg | 14.3% | 15.2% | 14.1% | 11.8% | -6.0% | 25.8% | 3.8% | 25.6% | -8.5% | 16.4% | 14.6% |
| Risk Measures | |
| Standard Deviation: | na |
| Total Risk Index: | na |
| Category Risk Index: | na |
| Category Risk Grade: | |
| Beta: | na |
| R-Squared: | na |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Value |
| Bond Investment Style: | na |
| Yield: | 0.4% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $17 Mil |
| Fund Total Assets: | $ 17 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 12% |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 1.0 years | |||
| Average Tenure: 1.0 years | |||
| Managers (Year): Caylor Ryan (2025), Doll Robert (2025) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 54 |
| % in Top 10 Holdings: | 27.8% |
| Fund is Non-Diversified: | Yes |
| % in Foreign Issues: | 10.3% |
Portfolio Allocation |
|
| Domestic Stock: | 89.6% |
| Foreign Stock: | 10.3% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.1% |
Purchase Information
| Fund Family: | Crossmark Inc |
| Phone Number: | 888-845-6910 |
| Website: |
| Status: | Open |
| Inception Date: | July 22, 2025 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.50% ( Rating : Avg ) |
| Category Average Expense Ratio (%): | 0.93% |
| Share Class: | Crossmark Large Cap Value ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.